Poster Presentation

TSND-201 for the Treatment for PTSD: Functional and Global Improvements from the Open-Label Portion of the IMPACT-1 Study (T36)

TSND-201 for the Treatment for PTSD: Improvement in Sleep-Related Outcomes from the Open-label Portion of the IMPACT-1 Study (W45)

TSND-201, a rapid-acting treatment for PTSD and other Central Nervous System (CNS) disorders (T89)

TSND-201 (methylone) for PTSD: Initial Results from Open-Label Study (IMPACT-1)

Methylone: Distinct Pharmacological and Mechanistic Effects Compared with MDMA

Methylone, a rapid-acting entactogen with robust anxiolytic and antidepressant-like activity

Naturalistic Clinical Evidence for the Use of Methylone in the Treatment of PTSD: A Case Series

Methylone with Robust Antidepressant-Like Activity in the Forced Swim Test